RxDoctor Payments Data

Brandon Harris, MD

Interventional Pain Medicine · Cincinnati, OHNPI 1043464951

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,660 of the $12,224 with a category attached, or 87.2%. 24 manufacturers reported payments, led by Abbott at 24.5% of the total. Reporting peaked in 2023 at $3,565 and has fallen 58.4% since, to $1,483 in 2025.

$12,224in general payments, 2019–2025

Across 205 payments — averaging $59.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Stryker$2K
  • Vertos Medical, Inc.$2K
  • Boston Scientific$1K
  • Medtronic$737
  • Relievant Medsystems, Inc.$584
  • plus $3K from 18 others

What the payments were for

  • Travel & lodging$1,55313%
  • Food & beverage$10,66087%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,224 in reported general payments places this provider in the 70th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$346,053
Medicare patients
415
Services billed
2,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,303$22,317
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen719$11,411
Gabapentin367$3,815
Acetaminophen-CodeineAcetaminophen With Codeine50$1,986
Oxycodone Hcl136$1,758
Fentanyl34$1,717
Pregabalin75$1,639
Tramadol Hcl218$1,396
Celecoxib43$1,312
Hydromorphone Hcl59$762
Tizanidine Hcl117$558
Morphine Sulfate ErMorphine Sulfate27$519
Cyclobenzaprine Hcl47$334
Diclofenac Sodium13$300
Baclofen19$108

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →